Jemma Geoghegan

Last updated

Jemma Geoghegan
Born1985or1986(age 37–38)
Cupar, Fife, Scotland
Alma mater University of Otago
Known for
Scientific career
FieldsGenome sequencing
Institutions Macquarie University
University of Otago
Thesis Modelling selection under soft inheritance  (2012)
Doctoral advisor Hamish Spencer

Jemma Louise Geoghegan (born 1985or1986) [1] is a Scottish-born evolutionary virologist, based at the University of Otago, New Zealand, who specialises in researching emerging infectious diseases and the use of metagenomics to trace the evolution of viruses. As a leader in several government-funded research projects, Geoghegan became the public face of genomic sequencing during New Zealand's response to COVID-19. Her research has contributed to the discussion about the likely cause of COVID-19 and the challenges around predicting pandemics. She was a recipient of the Young Tall Poppy Award in 2017, a Rutherford Discovery Fellowship in 2020, and the 2021 Prime Minister's Emerging Scientist Prize.

Contents

Early life and education

Geoghegan was born and raised in Cupar, Scotland. She was accepted into the University of Strathclyde, Glasgow, but in 2004 took a year off school before starting her university studies to work as a volunteer teacher in Baddegama, Sri Lanka. [1] At the age of 18, she returned to the University of Strathclyde and completed her Bachelor of Science (Honours) in Genetics, specialising in Forensic Biology in 2009. [2] She received a scholarship to do a doctorate at the University of Otago and moved to New Zealand. She was offered the opportunity to do the PhD by Professor Hamish Spencer, who said he "chose Geoghegan for the post because of her 'interesting' background." [2] On completion of her PhD in evolutionary biology in 2012, [3] Geoghegan went to New York where she worked with a group at New York University that was focused on HIV. In 2013 she moved to Australia and worked as a postdoctoral research fellow at the University of Sydney from 2013 to 2017, before getting her own laboratory at Macquarie University. [1]

Career

Geoghegan worked as a lecturer at Macquarie University from 2017 to 2020. [4] In 2017 for her research as an evolutionary biologist, she received the Tall Young Poppy Award. [5]

Since 2020 Geoghegan has been a senior lecturer in the University of Otago's microbiology and immunology department and an associate senior scientist at the Institute of Environmental Science and Research (ESR). In August 2023 she was promoted to the Webster Family Chair in Viral Pathogenesis at Otago. [6]

Genome sequencing

Public profile

Geoghegan has been described as one of New Zealand's "standout communicators... one of the faces of this country's COVID-19 genome sequencing efforts." [1] Writing in The Spinoff, the New Zealand-based scientist Siouxsie Wiles acknowledged Geoghegan as "one of the people behind New Zealand's incredible efforts to sequence all the strains of the virus we get here." [7] Wiles also recommended that those interested in learning more about genome sequencing should check out research being developed by a team that included Geoghegan. [8] The paper for this research was later published on 11 December 2020. [9] The Guardian acknowledged Geoghegan as "one of the scientists leading work to analyse genomic sequences of the virus." [10]

When Britain decided in July 2021 to lift all public health restrictions following lockdowns during COVID-19 despite only half of the population being vaccinated, Geoghegan shared the concerns of Siouxsie Wiles, Ashley Bloomfield and Julie Anne Genter that this was likely to lead to more dangerous virus variants circulating worldwide, undermining vaccination programmes. She said this was "[training] the virus to escape vaccine-induced immunity", and the country needed a higher threshold of vaccination to deal with the Delta variant. [11]

In January 2022 as the Omicron variant began circulating New Zealand and it appeared that there would be a further mutation, BA.2, [12] Geoghegan noted that "the new mutation is largely found through genome sequencing as only certain types of PCR (nasal swab) tests pick up the subtle differences between Delta and BA.2...[but that]...people who are fully vaccinated with boosters were "effectively protected" against the new variant. [13] By June 2022 it was widely held that Omicron would likely become endemic in New Zealand. Considering the implications of this, one commentator wrote, "the only determinants of how many people will be sickened, disabled or killed by the virus are its evolutionary leaps and our actions to shape its environment." [14] Geoghegan agreed that the host and the virus are in an "evolutionary arms race where they keep changing to try and beat each other", but noted it is difficult to predict how the virus could change as new variants attempt to evade immunity from vaccination or prior infection. She said factors such as "rapidly replicating and infecting cells inside a chronic, immunocompromised person...[or]...a recombination of different variants, perhaps in an animal host" could affect this. [14]

Debate on the causes of COVID-19

Early 2020 when questions were being asked about the causes of the coronavirus pandemic, Geoghegan was asked on 7 News, as a scientist whose "expertise focuses on the area where animals and humans meet", if and how COVID-19 had jumped from animals to humans. She explained that bats do contain viruses similar to COVID-19, but to confirm they were "genetically related", it was necessary to look at the "genetic signatures" in the virus. [15] In 2018 Geoghegan had participated in a research study that used a metagenomics lens to show by examination of the genome sequencing of viruses in fish as the ancestors of all vertebrates, how a virus can spread and evolve through time and space, confirming it exists in nature and not necessarily made by humans. [16] She has noted that the genome of SARS-CoV-2, the virus that causes COVID-19, is closely related to other viruses that are present in nature and that as a new SARS virus, the coronavirus was likely to have taken a similar route to that which caused the SARS outbreak in 2003 when it was spread from live animals to humans. Geoghegan concluded, "human interactions with live animals make a host jump more likely to occur, and live animal markets are a massive source of these interactions." [17]

Predicting viruses

Geoghegan published an article in the Australasian Science Journal (2016) that researched the role of biological factors such as the size, structure and mode of transmission of viruses in predicting their risk of being transmissible amongst humans. [18] In the same year she collaborated on research with Edward Holmes that explores whether viruses could be predicted. [19] When discussing the research with Ed Yong at The Atlantic, Geoghegan said prediction is difficult because of the vast number of viruses and supported the conclusions of another scientist, Kristian Anderson, from Scripps Research Institute when he said it was "simply impossible...[to predict]...whether a newly discovered animal virus could jump into humans and cause a pandemic." [20] In the article, Geoghagen argued that it is best to identify "fault lines" where animals and people interact. Yong concluded: "The kind of surveillance that Geoghagen, Andersen, and others are calling for...[is]...vital." [20] In May 2020, Geoghegan told The Sydney Morning Herald, that the best way to gain knowledge of possible prediction of viruses is to fund surveillance of people, particularly in places where they interact with live animals and identify the "risk zones" [21] Introduced by Kate Hawkesby on Newstalk ZB as "an expert in genome sequencing", Geoghegan explained that when a virus jumps from person to person, it creates a new mutation that could be tracked in terms of origin and possible spread in the community. [22]

Avian influenza

In August 2023, Geoghegan co-authored an article warning new strains of avian influenza (known as bird flu) were causing a worldwide panzootic amongst aquatic birds, with [increasingly common] "spillovers to non-avian hosts such as mammals". [23] The article noted that as of 2023 there had been no cases of the variants in New Zealand, but cautioned the country was vulnerable because of the high number of migratory birds that come each year, some of which may experience asymptomatic infections. The authors noted that New Zealand had little surveillance of active viruses in wildlife and suggested a series of steps the country could take to be prepared for incursions. These would include raising awareness when there are unexpected deaths of animals, increasing targeting of known pathogens and maximising the use of the "viral genomics capabilities...established during COVID-19." [23]

Selected research projects

Institute of Environmental Science and Research

In May 2020 as a result of a collaboration between Otago University and the Institute of Environmental Science and Research (ESR), Geoghegan was allocated $600,000 from the Ministry of Business, Innovation and Employment (MBIE) COVID-19 Innovation Acceleration Fund. Her role was to lead an international team of scientists to sequence the genomes of all of New Zealand's positive COVID-19 cases and track how the virus spread across New Zealand. [24] By August 2020, the team was able to show genomic sequencing confirming that the origin of the virus in New Zealand was from overseas, and was mostly spread within the country at social gatherings. [25] When Auckland had another community outbreak of the virus in August 2020, Geoghegan told Kathryn Ryan on RNZ National that the work she was involved in with the ESR could identify which quarantine facility or border outpost the virus had originated from and compare the genomes of the new cases to the ones from the "managed-isolation facilities", or from around the world. [26]

In a podcast Geoghegan explained how genome sequencing worked and that internationally the data gathered was being shared as a rapid response to COVID-19. [27] Following the second outbreak of the virus in the New Zealand community in August 2020, Geoghegan said:

It is vital that genomics is part of this response to enable us to track where these cases may have arisen and to estimate the size and number of clusters present...[and]...by comparing the virus genomes from these cases to those from both the quarantine facilities and the global population, we can determine their likely origin and how long they have been circulating in the community. [28]

In November 2020, when an aircrew member who had arrived in New Zealand from overseas tested positive, Geoghegan reiterated the importance of genome sequencing to establish whether the virus related to local or global infections and the likelihood that transmission of the cases occurred during the flight. [29]

Rutherford Discovery Fellowship

On 22 October 2020, the Royal Society Te Aparangi announced that Geoghegan was awarded the government-funded Rutherford Discovery Fellowship. The $800,000 scholarship would fund Geoghegan's study, which was entitled Ecological barriers and drivers of virus emergence. Its aim was to show "how viruses evolve to make the jump to a new host species, by sequencing RNA from diverse animal species in New Zealand and analysing any viruses present". Geoghegan described this as significant in the context of the COVID-19 pandemic, and would be the "first study examining virus ecology and evolution of such magnitude in this country. [30] [31]

In 2021, Geoghegan's work continued and was focused initially on the UK virus variant that had broken out in New Zealand. She said that the variant did contain a "few mutations that were likely increasing the rate of transmission...[but]...the biggest driver of virus spread is a population that doesn't have any immunity, which is basically all of New Zealand." [32]

Awards

In 2017 Geoghegan gained The Young Tall Poppy Award run by the Australian Institute of Policy and Science (AIPS). Geoghegan said that she was very passionate about communicating research findings to the wider community and the award was an opportunity for her to become more skilled in this area. [33]

Geoghegan received the Genetics Society of Australia Alan Wilton Award to recognise outstanding contributions to the field of genetics research by Australasian scientists early in their career in 2017. [34]

In 2017 she won the Macquarie University Faculty of Science and Engineering Excellence in Early Career Research Prize. [35]

In May 2022 Geoghegan was awarded the 2021 Prime Minister's Emerging Scientist prize, worth $200,000. [36] In North & South magazine, Paul Gorman wrote that "hundreds, if not thousands, of New Zealanders are still alive thanks to Geoghegan and colleagues tracking outbreaks of the Delta variant during the elimination phase of the pandemic. Some contemporaries believe she has helped save millions of lives around the world due to people avoiding the virus." [2] Geohegan acknowledged that by receiving the award she was challenging the stigma around women in science, and "planned to use the funds from the award to support further research and student training." [37]

Related Research Articles

<span class="mw-page-title-main">Institute of Genomics and Integrative Biology</span> Indian scientific research institute

CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB) is a scientific research institute devoted primarily to biological research. It is a part of Council of Scientific and Industrial Research (CSIR), India.

Dr Vinod Scaria FRSB, FRSPH is an Indian biologist, medical researcher pioneering in Precision Medicine and Clinical Genomics in India. He is best known for sequencing the first Indian genome. He was also instrumental in the sequencing of The first Sri Lankan Genome, analysis of the first Malaysian Genome sequencing and analysis of the Wild-type strain of Zebrafish and the IndiGen programme on Genomics for Public Health in India.

<span class="mw-page-title-main">Siouxsie Wiles</span> New Zealand microbiologist and science communicator

Siouxsie Wiles is a British microbiologist and science communicator. Her specialist areas are infectious diseases and bioluminescence. She is based in New Zealand.

Sharon Jayne Peacock is a British microbiologist who is Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge. Peacock also sits on Cambridge University Council.

<span class="mw-page-title-main">Philippine Genome Center</span>

The Philippine Genome Center (PGC) is a multi-disciplinary research facility in Quezon City, Metro Manila, Philippines which specializes in genomics.

<span class="mw-page-title-main">COVID-19 pandemic in New Zealand</span> Ongoing COVID-19 viral pandemic in New Zealand

The COVID-19 pandemic in New Zealand was part of the pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The first case of the disease in New Zealand was reported on 28 February 2020. The country recorded over 2,274,370 cases. Over 3,000 people died as a result of the pandemic, with cases recorded in all twenty district health board (DHB) areas. The pandemic first peaked in early April 2020, with 89 new cases recorded per day and 929 active cases. Cases peaked again in October 2021 with 134 new cases reported on 22 October.

Samira Mubareka is a Canadian microbiologist who is a clinical scientist at the Sunnybrook Health Sciences Centre in Toronto, Ontario. Her research considers the influenza virus, viral transmission and aerobiology. During the COVID-19 pandemic Mubareka isolated the genome of Severe acute respiratory syndrome coronavirus 2 in an effort to improve detection and diagnostics. She served as a member of the Ontario COVID-19 Science Advisory Table.

<span class="mw-page-title-main">COVID-19 pandemic and animals</span> Overview of the impact of the COVID-19 pandemic on animals

The COVID-19 pandemic has affected animals directly and indirectly. SARS-CoV-2, the virus that causes COVID-19, is zoonotic, which likely to have originated from animals such as bats and pangolins. Human impact on wildlife and animal habitats may be causing such spillover events to become much more likely. The largest incident to date was the culling of 14 to 17 million mink in Denmark after it was discovered that they were infected with a mutant strain of the virus.

<span class="mw-page-title-main">SARS-CoV-2 Alpha variant</span> Variant of SARS-CoV-2, the virus that causes COVID-19

The Alpha variant (B.1.1.7) was a SARS-CoV-2 variant of concern. It was estimated to be 40–80% more transmissible than the wild-type SARS-CoV-2. Scientists more widely took note of this variant in early December 2020, when a phylogenetic tree showing viral sequences from Kent, United Kingdom looked unusual. The variant began to spread quickly by mid-December, around the same time as infections surged.

<span class="mw-page-title-main">SARS-CoV-2 Beta variant</span> Variant of the SARS-CoV-2 virus

The Beta variant, (B.1.351), was a variant of SARS-CoV-2, the virus that causes COVID-19. One of several SARS-CoV-2 variants initially believed to be of particular importance, it was first detected in the Nelson Mandela Bay metropolitan area of the Eastern Cape province of South Africa in October 2020, which was reported by the country's health department on 18 December 2020. Phylogeographic analysis suggests this variant emerged in the Nelson Mandela Bay area in July or August 2020.

<span class="mw-page-title-main">COVID-19 Genomics UK Consortium</span> British genomics research consortium

The COVID-19 Genomics UK (COG-UK) consortium was a group of academic institutions and public health agencies in the United Kingdom created in April 2020 to collect, sequence and analyse genomes of SARS-CoV-2 at scale, as part of COVID-19 pandemic response.

<span class="mw-page-title-main">Variants of SARS-CoV-2</span> Notable variants of SARS-CoV-2

Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are of enough significance to lead virologists to label them separately. SARS-CoV-3 is the virus that causes coronavirus disease 2019 (COVID-19). Some have been stated, to be of particular importance due to their potential for increased transmissibility, increased virulence, or reduced effectiveness of vaccines against them. These variants contribute to the continuation of the COVID-19 pandemic.

<span class="mw-page-title-main">Zhang Yongzhen</span> Chinese virologist

Zhang Yongzhen, also known as Yong-Zhen Zhang, is a Chinese virologist known for his work relating to the COVID-19 pandemic. A professor at Fudan University, Zhang has discovered numerous RNA viruses and created a network of labs dedicated to monitoring new viruses. He led the team that sequenced and published the genome of SARS-CoV-2, the virus that causes COVID-19, in early January 2020.

<span class="mw-page-title-main">Origin of COVID-19</span> Inquiries into the origins of SARS-CoV-2

Since the beginning of the COVID-19 pandemic, there have been efforts by scientists, governments, and others to determine the origin of the SARS-CoV-2 virus. Similar to other outbreaks, the virus derived from a bat-borne virus and most likely was transmitted to humans via another animal in nature or during wildlife trade such as that in food markets. While other explanations such as speculations that SARS-CoV-2 was accidentally released from a laboratory have been proposed, such explanations are not supported by evidence. Conspiracy theories about the virus's origin have also proliferated.

<span class="mw-page-title-main">COVID-19 lab leak theory</span> Proposed theory on the origins of COVID-19

The COVID-19 lab leak theory, or lab leak hypothesis, is the idea that SARS-CoV-2, the virus that caused the COVID-19 pandemic, came from a laboratory. This claim is highly controversial; most scientists believe the virus spilled into human populations through natural zoonosis, similar to the SARS-CoV-1 and MERS-CoV outbreaks, and consistent with other pandemics in human history. Available evidence suggests that the SARS-CoV-2 virus was originally harbored by bats, and spread to humans from infected wild animals, functioning as an intermediate host, at the Huanan Seafood Market in Wuhan, Hubei, China, in December 2019. Several candidate animal species have been identified as potential intermediate hosts. There is no evidence SARS-CoV-2 existed in any laboratory prior to the pandemic, or that any suspicious biosecurity incidents happened in any laboratory.

INSACOG is the forum set up under the Ministry of Health and Family Welfare by the Government of India on 30 December 2020, to study and monitor genome sequencing and virus variation of circulating strains of COVID-19 in India. Initially it was tasked to study the virus variant Lineage B.1.1.7 earlier found in United Kingdom in December 2020.

Michael John Plank is an English-born professor in mathematics and statistics at the University of Canterbury, and a principal investigator at Te Pūnaha Matatini. Plank's research has focused on mechanistic mathematical and stochastic models and areas of expertise include ecological and social networks, population dynamics, epidemiological models and marine ecosystems. His work has included developing and applying models to the balanced managing of fishing sites, revitalisation of endangered languages and invasive plant and weed impact. As a Co-Lead for Covid-19 Modelling Aotearoa, a research programme established initially under Te Pūnaha Matatini but independent since 2021, he came to prominence as a COVID-19 modeller and frequent commentator in the media during the COVID-19 pandemic in New Zealand. Plank has received several awards in recognition of contributions to the field of applied mathematics, particularly for his explanations of how mathematical modelling can benefit social and ecological environments and concerns.

Tulio de Oliveira is a Brazilian, Portuguese, and South African permanent resident professor of bioinformatics at the University of KwaZulu-Natal and Stellenbosch University, South Africa, and associate professor of global health at the University of Washington. He has studied outbreaks of chikungunya, dengue, hepatitis B and C, HIV, SARS-CoV-2, yellow fever and Zika. During the COVID-19 pandemic he led the team that confirmed the discovery of the Beta variant of the COVID-19 virus in 2020 and the Omicron variant in 2021.

Te Pūnaha Matatini Centre for Complex Systems and Networks is a New Zealand Centre of Research Excellence that focusses on interpreting data about the environment, economy, and society to inform policy decision-making and public debate. Funded by the New Zealand Government, it is hosted by the University of Auckland and works in partnership with other universities and organisations, including Manaaki Whenua – Landcare Research. During the COVID-19 pandemic, Te Pūnaha Matatini developed mathematical models within different scenarios and provided data to inform the response of the New Zealand Government to the pandemic. Shaun Hendy, David Hayman and Michael Plank were among the high-profile members of the organisation who regularly commented on the COVID-19 pandemic in the news media at the time. The leadership of Te Pūnaha Matatini investigators has supported the setting up of independent research programmes, including Covid-19 Modelling Aotearoa and The Disinformation Project.

<span class="mw-page-title-main">David Hayman (disease ecologist)</span> New Zealand epizootic epidemiologist

David Hayman is a New Zealand-based epizootic epidemiologist and disease ecologist whose general multi-disciplinary work focuses on the maintenance of infectious diseases within their hosts and the process of emergence and transmission to humans specifically related to bats. He has gathered data on the relationship between ecological degradation due to anthropogenic actions, and increased pathogen emergence in humans and animals. During COVID-19 he was involved as an expert in several international collaborations, some convened by the World Health Organization, and was a regular commentator in the New Zealand media about the country's response to the pandemic. He has had lead roles in research organisations at Massey University and Te Pūnaha Matatini and was the recipient of the 2017 Rutherford Discovery Fellowship Award. Since 2014 Hayman has been a professor at Massey University.

References

  1. 1 2 3 4 UNI News (2 December 2020). "A modern-day explorer: Dr Jemma Geoghegan". University of Otago. The Otago Bulletin. Archived from the original on 3 December 2020. Retrieved 29 March 2021.
  2. 1 2 3 Gorman, Paul (October 2022). "The Virus Hunter". North & South. Archived from the original on 27 October 2022. Retrieved 27 October 2022.
  3. ↑ Geoghegan, Jemma (2013), Modelling Selection under Soft Inheritance (Doctoral thesis), OUR Archive, hdl:10523/3718, Wikidata   Q111965714
  4. ↑ "MICROBIOLOGY & IMMUNOLOGY Te Tari Moromoroiti me te Ārai Mate – Dr Jemma Geoghegan". micro.otago.ac.nz. Archived from the original on 5 March 2022. Retrieved 29 March 2021.
  5. ↑ "Macquarie Grows Our Tall Poppies Well: Evolutionary Biologist Dr Jemma Geoghegan Awarded". Macquarie University. Newsroom. 21 August 2017. Archived from the original on 24 August 2017. Retrieved 29 March 2021.
  6. ↑ "New prestigious role for Professor Jemma Geoghegan". University of Otago. Archived from the original on 7 August 2023. Retrieved 7 August 2023.
  7. ↑ Wiles, Siouxsie (23 November 2020). "Aches on a plane – new findings on in-flight Covid transmission revealed". The Spinoff. Archived from the original on 22 November 2020. Retrieved 29 March 2021.
  8. ↑ Wiles, Siouxsie (13 August 2020). "How genome sequencing could crack the case of the NZ Covid comeback". The University of Auckland. Archived from the original on 19 August 2020. Retrieved 4 April 2021.
  9. ↑ Geoghegan, Jemma L.; et al. (11 December 2020). "Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand". Nature Communications. 11 (6351): 6351. Bibcode:2020NatCo..11.6351G. doi: 10.1038/s41467-020-20235-8 . PMC   7733492 . PMID   33311501.
  10. ↑ McClure, Tess (3 April 2021). "How New Zealand's Covid success made it a laboratory for the world". The Guardian. Archived from the original on 3 April 2021. Retrieved 4 April 2021.
  11. ↑ Daalder, Marc (13 July 2021). "UK's 'awful experiment' will threaten NZ". Newsroom. Archived from the original on 12 July 2021. Retrieved 14 July 2021.
  12. ↑ Bernstein, Lenny (24 January 2022). "There's a new version of omicron but so far it doesn't appear to be more dangerous". The Washington Post. Archived from the original on 25 January 2022. Retrieved 30 January 2022.
  13. ↑ "Covid-19: Booster dose effective against Omicron BA.2 mutation - virologist". RNZ. 28 January 2022. Archived from the original on 28 January 2022. Retrieved 30 January 2022.
  14. 1 2 Daalder, Marc (15 June 2022). "Covid isn't over, it's just getting started". Newsroom. Archived from the original on 16 June 2022. Retrieved 16 June 2022.
  15. ↑ Pratt, Rodney; Ku, Jenny (16 April 2020). "Coronavirus: Virologist explains how COVID-19 jumped from animals to humans, and why we can't predict the next pandemic". 7 News. The Morning Show. Archived from the original on 16 April 2020. Retrieved 30 March 2021.
  16. ↑ Geoghegan, Jemma L.; et al. (31 October 2018). "Hidden diversity and evolution of viruses in market fish". Virus Evolution. 4 (2): vey031. doi: 10.1093/ve/vey031 . PMC   6208713 . PMID   30397510. Archived from the original on 20 March 2020.
  17. ↑ Lyons, Suzannah; Mitchel, Natasha (9 April 2020). "How did coronavirus start? Where did bats get the virus from and how did it spread to humans?". ABC News. Archived from the original on 9 April 2020. Retrieved 29 March 2021.
  18. ↑ Geoghegan, Jemma (2016). "Predicting Pandemics". Australasian Science. Permission given by Guy Nolich Control Publishing(30 March 2021) to link to this article. Archived from the original on 30 September 2016. Retrieved 1 April 2021.{{cite journal}}: CS1 maint: location (link)
  19. ↑ Geoghegan, Jemma L.; Holmes, Edward G. (25 October 2017). "Predicting virus emergence amid evolutionary noise". Open Biology. Royal Society. 7 (10): 170189. doi: 10.1098/rsob.170189 . PMC   5666085 . PMID   29070612.
  20. 1 2 Yong, Ed (26 October 2017). "Is It Possible to Predict the Next Pandemic?". The Atlantic. Archived from the original on 31 March 2022. Retrieved 29 March 2021.
  21. ↑ Mannix, Liam (16 May 2020). "Scientists tried to predict COVID-19. Here's why they missed it". The Sydney Morning Herald. Archived from the original on 16 May 2020. Retrieved 30 March 2021.
  22. ↑ Hawkesby, Kate (13 April 2020). "How genome sequencing can help track Covid outbreak". Newstalk ZB. Archived from the original on 18 September 2020. Retrieved 30 March 2021.
  23. 1 2 Geoghegan, Jemma; French, Nigel (18 August 2023). "Thousands of migratory birds will make NZ landfall in spring – will they bring a deadly bird flu with them?". The Conversation . Archived from the original on 22 August 2023. Retrieved 23 August 2023.
  24. ↑ "Dr Jemma Geoghegan receives $600,000 grant to track COVID-19 spread and evolution in NZ (Posted 29 May 2020)". Microbiology & Immunology. Otago University. Archived from the original on 5 August 2020. Retrieved 28 March 2021.
  25. ↑ Martin, Hannah (18 August 2020). "Coronavirus: New research reveals how Covid-19 came to New Zealand". Stuff. Archived from the original on 11 October 2021. Retrieved 28 March 2021.
  26. ↑ Nine to Noon (13 August 2020). "How genome testing could help reveal the source of community Covid". RNZ. Archived from the original on 23 August 2020. Retrieved 4 April 2021.
  27. ↑ Brett-Kelly, Sharon (20 August 2020). "The vital work of our genome scientists". Newsroom. Podcast: The Detail. Archived from the original on 20 August 2020. Retrieved 30 March 2021.
  28. ↑ Gibb, John (14 August 2020). "Covid 19 coronavirus: Genomic tracing used to find source of latest outbreak". New Zealand Herald. Archived from the original on 11 January 2021. Retrieved 29 March 2021.
  29. ↑ "Scientists awaiting results on Air New Zealand crew member with Covid-19". RNZ. 25 November 2020. Archived from the original on 7 April 2022. Retrieved 29 March 2021.
  30. ↑ Gibb, John (23 October 2020). "Scientific researchers get backing of fellowships". Otago Daily Times. Archived from the original on 27 November 2020. Retrieved 28 March 2021.
  31. ↑ "Latest 10 fellows announced in 10th year of Rutherford Discovery Fellowship awards (Published 22 October 2020)". Royal Society. Archived from the original on 1 November 2020. Retrieved 28 March 2021.
  32. ↑ MacLean, Hamish (16 February 2021). "Sequencing effort to identify virus variant". Otago Daily Times. Archived from the original on 17 February 2021. Retrieved 30 March 2021.
  33. ↑ Who's Who (21 August 2017). "Evolutionary biologist Dr Jemma Geoghegan recognised". getstem.co.au. Archived from the original on 13 April 2022. Retrieved 28 March 2021.
  34. ↑ "Past GSA Award Winners". Genetics Society of Australasia. Archived from the original on 7 March 2022. Retrieved 29 March 2021.
  35. ↑ "Macquarie University Faculty of Science and Engineering Excellence in Early Career Research (Jemma Geoghegan – Recipient 2017)". Macquarie University. Archived from the original on 27 April 2020. Retrieved 29 March 2021.
  36. ↑ "2021 TE PUIAKI KAIPŪTAIAO MAEA MACDIARMID EMERGING SCIENTIST |The Prime Minister's Science Prizes". Archived from the original on 31 May 2022. Retrieved 31 May 2022.
  37. ↑ Lewis, John (1 June 2022). "Genome sequencer Jemma Geoghegan claims Prime Minister's MacDiarmid Emerging Scientist Prize". Otago Daily Times. Archived from the original on 8 June 2022. Retrieved 30 October 2022– via New Zealand Herald.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.